| 1 |
29173042 | Antithrombin conformational modulation by D-myo-inositol 3,4,5,6-tetrakisphosphate (TMI), a novel scaffold for the development of antithrombotic agents. | 2018 Nov |
1 |
| 2 |
22315264 | Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | 2012 Feb |
1 |
| 3 |
18574264 | Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | 2008 Jun |
1 |
| 4 |
17343367 | In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity. | 2007 Apr 3 |
1 |
| 5 |
15957976 | Clinical use of enoxaparin in the management of non-ST segment elevation acute coronary syndromes. | 2005 Jun |
1 |
| 6 |
14596625 | Glycosaminoglycans bind factor Xa in a Ca2+-dependent fashion and modulate its catalytic activity. | 2003 Nov 11 |
13 |
| 7 |
1962899 | Pharmacology of low molecular weight heparins. | 1990 Oct |
1 |
| 8 |
7112518 | Demonstration of a direct anti-factor Xa activity in certain heparin-related glycosaminoglycans. | 1982 Jun 15 |
1 |
| 9 |
6448846 | The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. | 1980 Nov 10 |
1 |